Farabi Pharmaceutical (XTEH:DFRB1) ROE % Adjusted to Book Value: 0.00% (As of . 20)


What is Farabi Pharmaceutical ROE % Adjusted to Book Value?

Farabi Pharmaceutical XTEH:DFRB1 ROE % Adjusted to Book Value is 0.00% as of . 20.

Farabi Pharmaceutical's ROE % for the quarter that ended in . 20 was 0.00%. Farabi Pharmaceutical's PB Ratio for the quarter that ended in . 20 was N/A. Farabi Pharmaceutical's ROE % Adjusted to Book Value for the quarter that ended in . 20 was N/A.

Farabi Pharmaceutical ROE % Adjusted to Book Value Related Terms

Farabi Pharmaceutical ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical ROE % Adjusted to Book Value Chart

Farabi Pharmaceutical Annual Data
Trend
ROE % Adjusted to Book Value

Farabi Pharmaceutical Quarterly Data
ROE % Adjusted to Book Value

XTEH:DFRB1 vs IMNPQ, INNV: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Farabi Pharmaceutical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farabi Pharmaceutical ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Farabi Pharmaceutical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Farabi Pharmaceutical's ROE % Adjusted to Book Value falls into.


Farabi Pharmaceutical ROE % Adjusted to Book Value Calculation

Farabi Pharmaceutical's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Farabi Pharmaceutical's ROE % Adjusted to Book Value for the quarter that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a ROE % Adjusted to Book Value of 0.00% as of . 20. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's ROE % Adjusted to Book Value too high?
Farabi Pharmaceutical's current ROE % Adjusted to Book Value is 0.00%.
How does Farabi Pharmaceutical's ROE % Adjusted to Book Value compare to IMNPQ and INNV?
Farabi Pharmaceutical's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Farabi Pharmaceutical and its competitors. Farabi Pharmaceutical's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current ROE % Adjusted to Book Value is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.